These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36804120)

  • 1. Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axis.
    Li Y; Hu Y; Yang L; Liu J; Cui C; Yang M; Zou D; Zhou L; Zhou Q; Ge W; Lang T
    Biomed Pharmacother; 2023 Apr; 160():114350. PubMed ID: 36804120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.
    Ning Y; Feng W; Cao X; Ren K; Quan M; Chen A; Xu C; Qiu Y; Cao J; Li X; Luo X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):19. PubMed ID: 30646963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalin Attenuates YAP Activity to Suppress Ovarian Cancer Stemness.
    Li Y; Wang D; Liu J; Li Y; Chen D; Zhou L; Lang T; Zhou Q
    Onco Targets Ther; 2020; 13():7151-7163. PubMed ID: 32801747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOTAIR maintains the stemness of ovarian cancer stem cells via the miR-206/TBX3 axis.
    Zhang Y; Guo J; Cai E; Cai J; Wen Y; Lu S; Li X; Han Q; Jiang J; Li T; Wang Z
    Exp Cell Res; 2020 Oct; 395(2):112218. PubMed ID: 32771526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
    He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
    Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.
    Ning Y; Cui Y; Li X; Cao X; Chen A; Xu C; Cao J; Luo X
    Biomed Pharmacother; 2018 Jul; 103():262-271. PubMed ID: 29656182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.
    Chen Y; Fang R; Yue C; Chang G; Li P; Guo Q; Wang J; Zhou A; Zhang S; Fuller GN; Shi X; Huang S
    Cancer Res; 2020 Mar; 80(5):1049-1063. PubMed ID: 31888886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm.
    Wu X; Wang Y; Zhong W; Cheng H; Tian Z
    Med Sci Monit; 2020 May; 26():e922012. PubMed ID: 32433460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics.
    Han K; Lang T; Zhang Z; Zhang Y; Sun Y; Shen Z; Beuerman RW; Zhou L; Min D
    Sci Rep; 2018 Jun; 8(1):8537. PubMed ID: 29867083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
    Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway.
    Zhao N; Zhou L; Lu Q; Wang S; Sun Y; Ding Y; Liu M; He H; Lang T
    Exp Eye Res; 2022 Jan; 214():108887. PubMed ID: 34890603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist.
    He Y; Alejo S; Venkata PP; Johnson JD; Loeffel I; Pratap UP; Zou Y; Lai Z; Tekmal RR; Kost ER; Sareddy GR
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis.
    Wang K; Wang Y; Wang Y; Liu S; Wang C; Zhang S; Zhang T; Yang X
    Stem Cell Res Ther; 2021 Mar; 12(1):186. PubMed ID: 33726845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
    Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
    Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
    Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.
    Yamamoto S; Tateishi K; Kudo Y; Yamamoto K; Isagawa T; Nagae G; Nakatsuka T; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Aburatani H; Omata M; Koike K
    Carcinogenesis; 2013 Oct; 34(10):2380-8. PubMed ID: 23698634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell.
    Lee HG; Shin SJ; Chung HW; Kwon SH; Cha SD; Lee JE; Cho CH
    J Gynecol Oncol; 2017 Mar; 28(2):e14. PubMed ID: 27894167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.
    Wilczyński JR; Wilczyński M; Paradowska E
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
    Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2.
    Peng Q; Qin J; Zhang Y; Cheng X; Wang X; Lu W; Xie X; Zhang S
    J Exp Clin Cancer Res; 2017 Nov; 36(1):171. PubMed ID: 29187221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.